Trial Twice Daily Application of LEO 124249 Ointment 30 mg/g in Treatment of Mild to Moderate Inverse Psoriasis
Clinical trial NCT02695940 · COMPLETED
Trial details
- NCT number
- NCT02695940
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2016-09-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.